EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY 4.0

The building blocks of phage therapy: from lytic phage identification to preclinical validation against antimicrobial-resistant critical priority bacteria

Filipa F Vale iD

Microbiology Spectrum · 02.06.2026 · 14 (6)

DOI: 10.1128/spectrum.00507-26 ↗

Kurz gefasst

Kommentar in der Zeitschrift Microbiology Spectrum, erschienen am 02.06.2026. Verfasst von Filipa F Vale. Beteiligte Einrichtung: BioISI - Instituto de Biossistemas e Ciências Integrativas, Faculdade de Ciências, Universidade de Lisboa, Lisboa, Portugal. Hauptthemen laut MEDLINE: Phage Therapy, Bacteriophages, Enterobacter cloacae, Enterobacteriaceae Infections. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The fight against antimicrobial resistance is bringing back phage therapy, consisting of the use of lytic phages against specific pathogenic bacteria. For this purpose, libraries of well-characterized lytic phages are crucial, as the phage–bacteria arms race can limit efficacy, making phage cocktails generally more effective. In a recent study by H. -Y. Kuo, C. J. B. Bregente, T. T. D. Thuy, J. H. Hidrosollo, et al. (Microbiol Spectr 13:e00835-25, 2025, https://doi.org/10.1128/spectrum.00835-25 ), 12 novel lytic phages were isolated against carbapenem-resistant Enterobacter cloacae complex, a WHO critical-priority pathogen. These phages showed antibacterial activity in vitro and a broad host range across a panel of 80 CR-ECC isolates, as well as improved survival in the invertebrate model Galleria mellonella . Testing the two most promising phages in a mouse model showed that one significantly enhanced survival, demonstrating its therapeutic potential. This study offers a roadmap for isolating, characterizing, and evaluating phages for therapeutic use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phage TherapyBacteriophagesEnterobacter cloacaeEnterobacteriaceae InfectionsAnimalsAnti-Bacterial AgentsHumansMiceDrug Resistance, BacterialHost Specificity

Stichwörter der Autor:innen

EnterobacterEnterobacter cloacae complexantibiotic resistancebacteriophage therapy

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • BioISI - Instituto de Biossistemas e Ciências Integrativas, Faculdade de Ciências, Universidade de Lisboa, Lisboa, Portugal.

ORCID-Profile: Filipa F Vale

Zitieren

APA

Vale, F. F. (2026). The building blocks of phage therapy: from lytic phage identification to preclinical validation against antimicrobial-resistant critical priority bacteria. Microbiology Spectrum, 14(6). https://doi.org/10.1128/spectrum.00507-26

Vancouver

Vale FF. The building blocks of phage therapy: from lytic phage identification to preclinical validation against antimicrobial-resistant critical priority bacteria. Microbiology Spectrum. 2026;14(6). doi:10.1128/spectrum.00507-26

BibTeX
@article{Vale2026,
  author = {Vale, Filipa F},
  title = {The building blocks of phage therapy: from lytic phage identification to preclinical validation against antimicrobial-resistant critical priority bacteria},
  journal = {Microbiology Spectrum},
  year = {2026},
  volume = {14},
  number = {6},
  doi = {10.1128/spectrum.00507-26}
}
Kostenlos starten →